SEC 13F Intelligence

Rock Springs Capital Management LP / IMMU

Rock Springs Capital Management LP’s Immunomedics Inc Position

Does Rock Springs Capital Management LP own Immunomedics Inc (IMMU)? Not currently — the last reported position was 1.59M shares worth $135M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$135M
Q3 2020
Shares
1.59M
% of Portfolio
+3.42%
Quarters Held
8
position exited

Position History IMMU

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $15MQ1 ’19Q2 ’19: $12MQ2 ’19Q3 ’19: $12MQ3 ’19Q4 ’19: $21MQ4 ’19Q1 ’20: $14MQ1 ’20Q2 ’20: $59MQ2 ’20Q3 ’20: $135MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20201.59M$135M+3.42%
Q2 20201.68M$59M+1.63%
Q1 20201.05M$14M+0.59%
Q4 20191.00M$21M+0.67%
Q3 2019895.0K$12M+0.47%
Q2 2019895.0K$12M+0.45%
Q1 2019800.0K$15M+0.59%
Q4 2018780.0K$11M+0.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of IMMU.